SWOT ANALYSIS OF JOHNSON & JOHNSON INDIA

LTD.
PHASE-1
INTRODUCTIOMN

Johnson & Johnson (J&J) India, a subsidiary of Johnson & Johnson USA, is one of the leading
players in the Indian pharmaceutical and consumer products business. It has employee strength
of over 1,800. It started business in India in 1947 in Bombay with Johnson’s Baby Powder, and,
over time, introduced other products like toothbrushes, Johnson’s Baby Cream and Prickly Heat
Powder.

Briefing about this world class company, we can have a glimpse on the following points:-

• Global Manufacturer of Pharmaceuticals, Consumer Products and Medical Devices.

• Listed in Fortune 500 Companies
• Ranked 1st among 50 top Pharmaceutical companies
• 230 subsidiary companies with operations in over 57 countries.
• Well known consumer products are the BAND-AID Brand line of bandages, TYLENOL
MEDICATIONS , JOHNSON’S BABY Products
• Produced its first products in 1886
• Incorporated in 1887
• ROBERT WOOD JOHNSON served as the first President of the company.
• In 1910,JAMES WOOD JOHNSON succeeded him as a President.
• William C. Weldon is the President ( since 2002 Onwards)

JOHNSON & JOHNSON IN INDIA

• Spread its roots in India during 1947.

• It was Mr. Patrick Whaley who set the foundation.
• Launched Johnson’s Baby cream and prickly Powder.
• Product like bellodomma, pharmaceutical tapes were imported from the parent company.
• In Sep. 1957 , a new company Johnson & Johnson India Ltd. Was created and
registered.
• Recently this company celebrated its 50 years in India.

VISION
The vision of Johnson's Baby is to partner with every mother around the
world to provide her baby with a happy, healthy start in life.

MISSION

Johnson & Johnson aspire to achieve business excellence through:

To make every baby a johnson’s baby

 • Culvating deep personal trust.
• Understanding mothers & baby’s rational and emotional needs.
• Recognizing the importance of healthcare professionals.

GOAL

To continue to drive the Baby Care market & successfully launch newer Products for different
end-users in 800+ Crore industries by 2014.

CREDO VALUES

• Our first responsibility – doctors, nurses, mothers, fathers, consumers.

• Everything of high quality.
• Constantly strive to reduce cost.
• Customers’ orders – serviced properly.
• Suppliers & distributors – make profit.
• Environment is the ultimate human health issue.

ENVIRONMENTAL POLICY

• Integrating Environmental goals.

• Striving for ZERO WASTE.
• 100% resource efficiency.
• Enhancement of environment.
• Utilizing innovative technologies.
• Fostering ENVIRONMENTAL ETHICS.

SEGMENTS OF BUSINESS

Johnson & Johnson is organized into three business segments:-

• Consumer
• Pharmaceutical
• Medical Devices and Diagnostics

MAJOR BRANDS

Some of the major Brands of J&J are :-

• AVEENO (Skin Care Products)

• BAND-AID (Brand Adhesive Bandages)
• CLEAN & CLEAR (Teen Skin Care Products)
• JOHNSON’S BABY (Baby Products)
• NEUTROGENA (Skin and Hair Care Products)
• REMBRANDT (Brand of Oral Care Products)
• SPLENDA (No Calorie Sweetener)
 PRODUCT MIX

J&J is known not only for the quality service & types of products but also for the variety &
range of products. It has a huge list of Product Lines with enormous depth in each line. It also
has a tremendous width & depth in its Product Mix. Its Product Lines are in the following
segments:-

Baby & Child Care

Skin Care

Oral and Wound Care

Women’s health Care

Nutritional and Over-the-counter

Pharmaceutical Products

Medical Devices and Equipment.

Some of the Products in the Product Line of Baby & Child Care are as:-

• Baby Hair Oil

• Baby Soap
• Baby Cream
• Baby Body Lotion
• Baby Massage Oil
• Baby Powder
• Baby Nappy Pads
• Baby Shampoo

J&J has done the Brand Line extension in the products like HAIR OIL, SOAP, CREAM,
MASSAGE OIL, POWDER & SHAMPOO by launching these products in various fragrance
& colours. In today’s changing times, where people have become more conscious towards their
health & thus moving towards natural products, they prefer using J&J products over other
Brands. J&J has captured the customers by positioning itself as a Company providing Natural
products devoid of chemicals. Thus its graph of Customer Confidence Index is high as compared
to other brands.

Not only the Kids & New Born, but also the teenagers & upper age group customers have been
the Target of J&J. it has its products flowing for every age group & in every segment. Some of
the products in the product line of SKIN CARE are:-

J&J also has its ORAL CARE products by the name Rembrandt. It also has its No Calorie
Sweetener by the name Splenda.

Product Line Length of J&J in PHARMACEUTICALS is huge. The products are for various
Therapeutic uses such as:-

• Anti Fungal
 • Anti-Infective

• Cardiovascular
• Contraceptive
• Dermatology
• Gastrointestinal and many more....

BRAND-AID is one of the most popular pharmaceutical products of J&J.

Product line of J&J in Medical Devices and Equipments is also quiet impressive.

• It includes a broad range of products distributed to Wholesalers, Hospitals & Retailers.

• Used principally in the professional fields by Physicians, Nurses, Therapists,

Hospitals, Diagnostic Laboratories and Clinics.
• Products include Cordis’ circulatory disease management products, DePuy’s orthopedic
joint reconstruction and spinal care products.
• Vistakon’s ACUBUE Disposable Contact Lens.
• One Touch Brand Blood Glucose Meters from LifeScan, Inc.
• P.F.C Sigma Knee System from DePuy, Inc.

J&J also have several women’s Health Care Products. Thus J&J has segmented the market in a
way so as to target Kids, Teenagers, Women and also people those are conscious about Natural
products. It has strongly covered the market by diversifying itself into Pharmaceuticals &
Manufacturer of Medical Equipments & devices.

TOP MANAGEMENT TEAM

Board of Directors

WILLIAMC.WELDON JAMES G.CULLEN

Chairman, Board of Directors Retired President & Chief
and Chief Executive Officer Operating Officer, Bell Atlantic
c Corporation
MARY S U E CO L E M A N , P H . D. MICHAEL M.E. Johns, M.D.
President, University of Michigan Chancellor, Emory University

ARNOLDG.LANGBO SUSAN L LINDQUIST, PH.D.

Retired Chairman and member & former director,
Chief Executive Officer, whitchead institute for
Kellogg Company Biomedical Research, Professor
o of Biology, Massachusetts
I Institute of Technology

A N N E M . M U LCA H Y LEO F. MULLIN

Chairman and Retired Retired Chairman & CEO,
Chief Executive Officer, Delta Airlines Inc.
Xerox Corporation

W I L L I A M D. P E R E Z CHARLES PRINCE
Senior Advisor, Greenhill & Co., Chairman, Sconset Group, LLC;
Inc.; Retired President and Senior Counsellor, Albright
Chief Executive Officer, Stonebridge Group; Retired
Wm. Wrigley Jr. Company Chairman& CEO, Citigroup
Inc.

DAV I D SATC H E R , M . D. , P H . D.
Director, Center of Excellence
on Health Disparities,
Director, Satcher Health
Leadership Institute and
Poussaint-Satcher-Cosby Chair
in Mental Health, Morehouse
School of Medicine; Former
U.S. Surgeon General

Corporate Officers
Wiliam C . Weldon
Chairman, Board of Directors
Chief Executive Officer
Chairman, Executive Committee

Dominic J. Caruso
Vice President, Finance
Chief Financial Officer
Executive Committee

Stephen J. Cosgrove
Corporate Controller

Laverne H . Council
Vice President,
Chief Information Officer

Rusel C . Deyo
Vice President, General Counsel
Executive Committee

Colen A . Gogins
Worldwide Chairman,
Consumer Group
Executive Committee

ALEXGOR SKY
Worldwide Chairman,
Medical Devices &
Diagnostics Group
Executive Committee

Raymond C . Jordan
Vice President, Public Affairs &
Corporate Communication

Sherilyn S . McCoy
Worldwide Chairman,
Pharmaceuticals Group
Executive Committee

John A . Papa
Treasurer

Brian D. Perkins
Vice President,
Corporate Affairs

Steven M . Rosenberg
Secretary,
Associate General Counsel

SUBSIDIARY HOLDINGS

Johnson & Johnson is a highly diversified company with atleast 230 subsidiaries, which it refers
to as the “Johnson & Johnson family of Companies”. Some of these subsidiaries include:

• ALZA Corporation.
• Baby Center, L.L.C.
• Johnson & Johnson, Group of Consumer Companies, Inc.
• Johnson & Johnson Health Care system Inc.
• Johnson & Johnson – Merck Consumer Pharmaceuticals Co.
• Johnson & Johnson Pharmaceutical Research & development, L.L.C.
 • Pfizer Consumer

COLLABORATION , JOINT VENTURES , MERGERS , ACQUISITION ,

& PARTNERSHIP

• In October 2009, Johnson & Johnson entered into a strategic collaboration with
Crucell NV, focusing on the discovery, development and commercialization of
monoclonal antibodies and vaccines for the treatment and prevention of influenza and
other infectious and non-infectious diseases.

• Johnson & Johnson and Tianjin Medical University Cancer Hospital in China
established a partnership in February 2008. At the hospital, tumor specimens are
collected from patients and catalogued, allowing scientists to identify biomarkers that
could help personalize medicine and advance cancer treatment.

• Johnson & Johnson acquired Cougar Biotechnology, Inc. in July 2009. Clinical trials
are under way on a compound for the treatment of prostate cancer, a disease that
accounts for 10 percent of cancer related deaths in the United States.

• In January 23, 2009-- Johnson & Johnson announced the completion of its
previously announced acquisition of Mentor Corporation, a leading supplier of
medical products for the global aesthetic market. Mentor is expected to operate as a
stand-alone business unit reporting through ETHICON, Inc., a Johnson & Johnson
company and a leading provider of suture, mesh and other products for a wide range of
surgical procedures. According to Gary Pruden, Company Group Chairman, Johnson &
Johnson, with responsibility for the ETHICON Franchise, “Mentor will become the
cornerstone of a broader Johnson & Johnson strategy for aesthetic medicine -- serving
both consumers and medical professionals. We will use our combined strengths and
experience to build a market-leading aesthetic business that capitalizes on Johnson &
Johnson’s broad-based commercial capabilities, worldwide surgical care footprint, and
clinical scientific capabilities.”

• 1959: McNeil Laboratories, Inc. (McNeil Labs) is acquired.

• 1961: Janssen Pharmaceutica is acquired.

• 1989: J & J and Merck form joint venture to develop OTC versions of Merck's
prescription medications.

• 1994: Neutrogena Corporation is acquired.

• 1995: Merck and J & J launch Pepcid AC; company acquires the clinical
diagnostics unit of Eastman Kodak Company.

• 1996: J & J acquires Cordis Corporation.

• 1998: DePuy, Inc. is acquired, and a companywide restructuring is launched.

• 1999: Centocor, Inc. merges with J & J.